INTRODUCTION
============

In humans, telomere shortening is regarded as a predictor of aging and aging-related diseases \[[@B1]\]. Telomeres are nucleoprotein complexes composed of short DNA repeats found at the ends of eukaryotic chromosomes. They are made up of TTAGGG sequence repeats and associated with sequence-specific binding proteins in humans \[[@B2]\]. These specialized ribonucleoprotein complexes protect the chromosome from degradation by nucleases, and inhibit abnormal DNA repair. Additionally, complexed structure of telomere plays a major role in genomic stability \[[@B3]\]. The loss of telomeric DNA occurs whenever the genome is replicated during cell division; this degradation proceeds progressively until the telomeres become critically shortened \[[@B4]\].

Many previous studies have suggested that a relatively short telomere length (TL) is associated with a higher risk of developing aging-related chronic diseases, particularly cardiovascular dysfunctions \[[@B5][@B6][@B7][@B8]\]. These results indicate that increased telomere shortening is a risk factor for the manifestation of aging-related cardiovascular disease (CVD), and is indicative of an active inflammatory response to oxidative stress \[[@B9]\]. Furthermore, genetic variants implicated in TL have been reported to be associated with the incidence of aging-related chronic diseases \[[@B10]\]. For example, two single nucleotide polymorphisms (SNPs) in *OBFC1* (rs10786775 C \> G, rs11591710 A \> C) were found to be associated with a higher risk of developing coronary heart disease (CHD), and three SNPs in *TERC* (rs12696304 C \> G, rs10936601 G \> T and rs16847897 G \> C) were correlated with a higher risk of CHD and the type II diabetes mellitus (T2DM) \[[@B11]\]. It was also reported that genetic variations in *BICD1* (rs2630578, rs1151026) and near *TERC* (rs16847897) were correlated with the manifestation of CVD. In a Japanese case study, genetic variations in *TERT* were significantly correlated with coronary artery disease (CAD) \[[@B12]\]. Moreover, in recent clinical studies, it was shown that subjects with a variant allele of rs398652 (associated with longer telomeres) have a significantly reduced risk of developing bladder cancer \[[@B13]\]. In addition, rs398652 genetic variants have an obvious impact on TL and esophageal squamous cell carcinoma susceptibility in Chinese populations \[[@B14]\]. While evidence for the causal role of TL variation in some chronic diseases has accumulated \[[@B15]\], the link between SNPs involved in telomere biology and the risk of hypertension (HTN), CHD, and its risk factors, has not been extensively studied in Korean populations. In this study, we examined whether SNPs previously reported to be associated with TL in humans are related to the incidence of HTN/CHD and risk factors of CVD, in a Korean population.

MATERIALS AND METHODS
=====================

Study population
----------------

Study subjects were obtained from two cohorts within the Korean Genome Epidemiology Study (KoGES): the rural Ansung and urban Ansan cohorts. The details of the KoGES have been described elsewhere \[[@B16]\]. Briefly, the Ansung and Ansan cohorts were designed as longitudinal prospective studies and initiated in 2001, with the aim of investigating risk factors for chronic diseases in Koreans. The KoGES included a health examination, interviews, and laboratory tests; it recruited 10,038 participants from each area (5,018 in Ansung and 5,020 in Ansan aged 39--70) using a two-stage cluster sampling method. Of the recruited participants, 1,196 individuals with poor genotyping data were excluded from the baseline data. This study was based on the baseline data collected in 2001, with subjects providing data for important analytic variables such as HTN, CHD, and 12 primary SNPs. Overall, 5,705 subjects were included in the statistical analysis. All participants provided written consent forms, a process approved by the Human Subjects Review Committee at Korea University Asan Hospital and the Ajou University Medical Center. This study was approved by the Institutional Review Board of Korea University (KU-IRB-14-EX-153-A-1).

General characteristics
-----------------------

Socio-demographic information including age, sex, residential area, educational level, physical activity, smoking status, and alcohol use were obtained from KoGES. Residential area was divided into a rural area, Ansung, and an urban area, Ansan. Education level was categorized into four levels, defined by the highest level of education received: elementary school, middle school, high school, and university. Physical activity was classified into two groups according to whether or not the individual performed any of the following daily activities: at least 20 minutes of intense physical activity, at least 30 minutes of moderate physical activity, or at least 30 minutes of walking. Subjects were divided into three groups according to their smoking status during the survey period, as follows: "nonsmoker," "ex-smoker," or "current smoker." Similarly, a current drinker was defined as a subject who drank alcoholic beverages regularly during the survey period.

Anthropometric and biochemical measurements
-------------------------------------------

Information on anthropometric and biochemical measurements was obtained from health examination data in KoGES, and originally collected by trained experts. Body mass index (BMI, kg/m^2^) was calculated by dividing the weight (kg) of an individual by their height squared (m^2^), which was measured to the nearest 0.1 cm or 0.1 kg, respectively. Waist circumference (WC, cm) was measured at the narrowest point between the lower rib and the iliac crest (measured to the nearest 0.1 cm), and the average of three repeated measurements was recorded. Blood pressure was measured while the individual was in a sitting position, using a mercury sphygmomanometer. The average of two repeated measurements was used. For laboratory tests, all participants fasted for at least an 8 hours period prior to blood collection. The levels of total cholesterol (TC, mg/dL), triglycerides (TG, mg/dL), HDL cholesterol (HDLC, mg/dL), fasting blood glucose (FBG, mg/dL), γ-glutamyl transpeptidase (GTP, IU/L), and high sensitivity C reactive protein (hs-CRP) were measured by Seoul Clinical Laboratories (Seoul, Korea). LDL cholesterol (LDLC, mg/dL) was calculated using the Friedewald formula in subjects with TG less than 400 mg/dL, as follows \[[@B17]\]:

LDL cholesterol = total cholesterol − HDL cholesterol − (triglycerides / 5.0)

For subjects with TG of 400 mg/dL or more, the LDLC value was marked as being unavailable.

Disease outcomes
----------------

Diagnoses of HTN and CHD were based on an evaluation of self-reported medical history. Subjects who were diagnosed with HTN, used blood pressure medicine, or presented with a systolic blood pressure reading greater than 140 mmHg or a diastolic blood pressure (DBP) reading greater than 90 mmHg were considered to exhibit HTN. CHD was diagnosed by clinical doctors or using self-reported questionnaire information on myocardial infarction (MI), and CAD.

DNA genotyping and imputation
-----------------------------

Detailed information on genotyping is provided elsewhere \[[@B16]\]. Briefly, DNA samples were isolated from the peripheral blood of participants and genotyped using the Affymetrix Genome-Wide Human SNP array 5.0 (Affymetrix, Inc., Santa Clara, CA, USA). The accuracy of the genotyping was calculated via Bayesian Robust Linear Modelling using the Mahalnobis Distance genotyping algorithm. Participants with a high missing genotype call rate, high heterozygosity, any kind of diagnosed cancer, and sex inconsistencies were excluded from the study. Furthermore, SNPs with high missing genotype call rates (\> 5%), minor allele frequencies (MAF) \< 0.01, and not in Hardy-Weinberg equilibrium (HWE, p value \< 1 × 10^-6^) were excluded. Ultimately, a total of 352,228 SNPs in 8,842 participants were used in the analysis. To obtain additional genotype information, SNP markers were imputed from a HapMap reference panel consisting of 3.99 million SNPs (HapMap release 22) in 90 individuals from Japanese individuals in Tokyo (JPT) and Han Chinese individuals from Beijing, China (CHB), using the IMPUTE software program (University of Oxford, Oxford, United Kingdom). In total, 1,804,397 SNPs remained after this process of quality control, from which SNPs with a minor allele frequency \< 0.01 or an information score \< 0.30 were removed.

Telomere length in relation to SNP selection
--------------------------------------------

Previous genome-wide association study (GWAS) publications focusing on telomeres were found using "telomere" or "telomere length" as keywords in the GWAS Catalog (<https://www.genome.gov/26525384>, 31 SNPs). Based on these previous studies, SNPs in "*TERT*" and "*TERC*," which are well known as TL-related genes, were also extracted from the GWAS Catalog (30 and 7 SNPs, respectively). We then searched two of the most recent GWAS publications in NCBI PubMed (<http://www.ncbi.nlm.nih.gov/pubmed/>), using the same keywords (2 SNPs). Of the 70 SNPs discovered during the previous GWAS studies \[[@B13][@B18][@B19][@B20][@B21][@B22][@B23][@B24][@B25][@B26]\], 8 genotyped SNPs and 4 imputed SNPs in independent genes were presented in our genotype data.

Statistical analyses
--------------------

Statistical analyses were performed using Stata SE 12.0 (Stata Corp., College Station, TX, USA). First, the distribution of variable values was investigated. FBG, HDLC, TG, γ-GTP, and hs-CRP were log-transformed. The general characteristics of the subjects were described as mean ± standard error (SE) for continuous variables, and as a frequency (%, n) for categorical variables. Differences in characteristics associated with disease status were determined using Student's t-test for continuous variables, and using χ^2^ tests for categorical variables. The association between selected SNPs and disease prevalence (HTN and CHD) was assessed using a logistic regression in an additive scale model, with adjustments for age, sex, area, BMI, education level, physical activity, smoking status, and alcohol use. The results are presented as the estimated odds ratio (OR) with 95% confidence intervals (95% CIs). To estimate the effect of alcohol use on these associations, the association between SNPs and disease outcomes was assessed using the same logistic regression model to analyze the data from alcohol users and non-users separately. Of the 12 SNPs, we selected three SNPs of interest in order to estimate the size of their effect size on cardiovascular risk factors. A linear regression model was used after adjustment for important covariates. Results are presented as estimated regression coefficients β with 95% CI. All statistical differences were determined at levels of p \< 0.05.

RESULTS
=======

General characteristics of the subjects
---------------------------------------

The general characteristics of the subjects are described in [Table 1](#T1){ref-type="table"}, according to the presence of HTN and CHD. The mean age was 48.2 ± 0.1 year, and nearly half of the subjects (49%) were male. HTN patients were older, and included higher proportions of subjects who were male, rural residents, alcohol users, ex-smokers, and less educated, compared to the control group (p \< 0.05). HTN patients also had a higher average blood pressure, BMI, WC, FBG, LDLC, TG, γ-GTP, and hs-CRP, and lower average HDLC than the control group (p \< 0.05). CHD patients were older, and had a higher average blood pressure, WC, TC, TG, and hs-CRP than the control group (p \< 0.05). The genotype frequencies of selected SNPs are presented in [Table 1](#T1){ref-type="table"}.

###### Baseline characteristics of the subjects
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  Characteristics               All (n = 5,705)   Hypertension         p value^†^           Coronary heart disease   p value^†^                                                
  ----------------------------- ----------------- -------------------- -------------------- ------------------------ --------------- -------------------- -------------------- --------
  Age, yr^\*^                   48.2 ± 0.1        47.3 ± 0.1           50.5 ± 0.2           \< 0.0001                48.2 ± 0.1      53.0 ± 0.6           \< 0.0001            
  Males, % (No.)                48.9 (2,792)      47.1 (1,936)         53.8 (856)           \< 0.0001                48.8 (2,754)    48.5 (38)            0.1220               
  Area, % (No.)                                                                             \< 0.0001                                                     \< 0.0001            
                                Rural (Ansung)    38.6 (2,202)         33.5 (1,379)         51.7 (823)               38.3 (2,159)    66.2 (43)                                 
                                Urban (Ansan)     61.4 (3,503)         66.5 (2,734)         48.3 (769)               61.7 (3,481)    33.9 (22)                                 
  Education level, % (No.)^‡^                                                               \< 0.0001                                                     0.0440               
                                ≤ Elementary      22.4 (1,269)         18.9 (775)           31.4 (494)               22.3 (1,249)    30.8 (20)                                 
                                ≤ Middle          25.1 (1,422)         24.8 (1,018)         25.6 (404)               25.0 (1,402)    30.8 (20)                                 
                                ≤ High            36.5 (2,074)         39.7 (1,628)         28.3 (446)               36.7 (2,061)    20.0 (13)                                 
                                ≥ University      16.1 (912)           16.6 (680)           14.7 (232)               16.0 (900)      18.5 (12)                                 
  Physical activity, % (No.)    84.4 (4,814)      84.3 (3,467)         84.7 (1,347)         0.7440                   84.4 (4,757)    87.7 (57)            0.4630               
  Alcohol use, % (No.)                                                                      0.0390                                                        0.0640               
                                Never             43.0 (2,441)         43.9 (1,797)         40.8 (644)               43.0 (2,414)    42.2 (27)                                 
                                Previous          5.8 (328)            5.4 (222)            6.7 (106)                5.7 (320)       12.5 (8)                                  
                                Current           51.2 (2,905)         50.7 (2,077)         52.5 (828)               51.3 (2,876)    45.3 (29)                                 
  Smoking, % (No.)                                                                          \< 0.0001                                                     0.0300               
                                Never             58.0 (3,271)         58.8 (2,399)         55.6 (872)               58.1 (3,243)    43.1 (28)                                 
                                Previous          15.3 (864)           13.9 (566)           19.0 (298)               15.2 (848)      24.6 (16)                                 
                                Current           26.8 (1,510)         27.3 (1,113)         26.3 (397)               26.7 (1,489)    32.3 (21)                                 
  SBP, mmHg                     118.9 ± 0.2       111.3 ± 0.2          138.5 ± 0.4          \< 0.0001                118.8 ± 0.2     126.7 ± 2.1          0.0003               
  DBP, mmHg                     79.6 ± 0.2        74.7 ± 0.1           92.3 ± 0.2           \< 0.0001                79.6 ± 0.2      83.1 ± 1.3           0.0159               
  BMI, kg/m^2^                  24.7 ± 0.0        24.3 ± 0.0           25.9 ± 0.1           \< 0.0001                24.7 ± 0.0      25.4 ± 0.3           0.0618               
  WC, cm                        82.0 ± 0.1        80.5 ± 0.1           86.0 ± 0.2           \< 0.0001                82.0 ± 0.1      86.2 ± 1.0           0.0001               
  FBG, log (mg/dL)              87.8 ± 0.3        86.0 ± 0.3           92.4 ± 0.7           \< 0.0001                87.7 ± 0.3      90.7 ± 2.6           0.1464               
  TC, mg/dL                     191.8 ± 35.9      189.4 ± 0.5          198.1 ± 1.0          \< 0.0001                191.7 ± 0.5     201.0 ± 4.7          0.0376               
  HDLC, log (mg/dL)             44.8 ± 0.1        45.2 ± 0.2           43.7 ± 0.2           \< 0.0001                44.8 ± 0.1      42.5 ± 1.1           0.0560               
  LDLC, mg/dL                   116.1 ± 0.4       115.0 ± 0.5          118.8 ± 0.9          0.0001                   116.0 ± 0.4     122.8 ± 4.0          0.0996               
  TG, log (mg/dL)               162.1 ± 1.4       151.9 ± 1.6          188.3 ± 3.0          \< 0.0001                161.8 ± 1.4     183.6 ± 13.7         0.0437               
  γ-GTP, log (IU/L)             36.5 ± 0.9        31.4 ± 0.8           49.6 ± 2.4           \< 0.0001                36.4 ± 0.9      39.0 ± 5.2           0.0763               
  hs-CRP, log (mg/dL)           0.219 ± 0.007     0.202 ± 0.007        0.262 ± 0.018        \< 0.0001                0.218 ± 0.007   0.232 ± 0.028        0.0099               
  Genotype, %^§^                                                                                                                                                               
                                rs11125529        72.6 / 25.0 / 2.5    72.2 / 25.2 / 2.6    73.4 / 24.4 / 2.1        0.4900          72.6 / 25.0 / 2.5    72.3 / 27.7 / 0.0    0.4050
                                rs12696304        54.4 / 38.7 / 6.9    55.1 / 38.3 / 6.7    53.0 / 39.5 / 7.5        0.3050          54.5 / 38.6 / 6.9    44.6 / 44.6 / 0.8    0.2080
                                rs10936601        54.2 / 38.4 / 7.4    54.8 / 38.1 / 7.2    52.9 / 39.2 / 7.9        0.3660          54.3 / 38.3 / 7.3    44.6 / 44.6 / 10.8   0.2440
                                rs2098713         24.2 / 48.8 / 17.0   34.6 / 48.3 / 17.1   33.2 / 48.8 / 17.0       0.4920          34.3 / 48.7 / 17.0   26.2 / 56.9 /16.9    0.3440
                                rs654128          93.3 / /6.7 / 0.1    93.3 / 6.7 / 0.1     92.5 / 7.5 / 0.0         0.3580          93.1 / 6.9 / 0.04    70.8 / 9.2 / 0.0     0.7540
                                rs17635722        75.6 / 22.9 / 1.5    75.5 / 23.0 / 1.5    75.6 / 22.7 / 1.7        0.7950          75.5 / 23.0 / 1.5    80.0 / 18.5 / 1.5    0.6890
                                rs398652          41.7 / 45.6 / 12.8   42.5 / 44.8 / 12.7   39.6 / 47.5 / 12.9       0.1320          41.8 / 45.5 / 12.8   33.9 / 52.3 / 13.9   0.4300
                                rs4902100         80.8 / 18.1 / 1.1    80.6 / 18.3 / 1.1    81.3 / 17.4 / 1.3        0.6100          80.9 / 18.0 / 1.1    76.9 / 23.1 / 0.0    0.4120
                                rs2535913         69.7 / 27.4 / 2.9    69.5 / 27.7 / 2.9    70.4 / 26.7 / 3.0        0.7580          69.8 / 27.3 / 2.9    63.1 / 35.4 / 1.5    0.3070
                                rs2162440         57.5 / 36.4 / 6.1    57.8 / 36.0 / 6.2    56.5 / 37.5 / 6.0        0.5630          57.5 / 36.4 / 6.1    55.4 / 40.0 / 4.6    0.7690
                                rs1975174         50.7 / 41.0 / 8.3    50.8 / 40.8 / 8.4    50.3 / 41.5 / 8.2        0.8920          50.7 / 40.9 / 8.4    52.3 / 44.6 / 3.1    0.2960
                                rs401681          45.4 / 44.1 / 10.5   46.3 / 43.3 / 10.4   43.0 / 46.2 / 10.8       0.0840          45.4 / 44.1 / 10.5   43.1 / 46.2 / 10.8   0.9310

SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; WC, waist circumference; FBG, fasting blood glucose; TC, total cholesterol; HDLC, high density lipoprotein cholesterol; LDLC, low density lipoprotein cholesterol; TG, triglycerides; γ-GTP, gamma-glutamyl transpeptidase; hs-CRP, high sensitivity C reactive protein; n, number.

^\*^Values are represented as mean ± standard error for continuous variables and number of counts and percentage for categorical variables. ^†^p values are from student's t-test for continuous variables and χ^2^ test for categorical variables assessing the difference between the groups. ^‡^Apart from major dependent variables (e.g. hypertension and coronary heart disease) and major independent variables (e.g. genotype), some variables included missing data points. ^§^The values were represented as percentage of the AA / Aa / aa genotype, respectively.

Association between telomere length-related SNPs and disease outcomes
---------------------------------------------------------------------

The associations between selected SNPs and HTN or CHD incidence are shown in [Table 2](#T2){ref-type="table"}. No significant associations between selected SNPs and disease outcome were observed in the overall population. Subjects who have minor alleles in rs12696304 of *TERC* exhibited a slightly higher, but not statistically significant OR for CHD. We further examined whether the association differed according to differences in lifestyle factors, such as alcohol consumption. Changes in association relative to alcohol status are presented in [Figure 1](#F1){ref-type="fig"}. Of the non-alcohol users, subjects with minor alleles in rs1269304 and rs10936601 (*TERC* and *LRRC34*, respectively) were at greatest risk of CHD (OR, 1.862; 95% CIs, 1.137, 3.049; OR, 1.855; 95% CIs, 1.111, 2.985; respectively). However, alcohol users with minor alleles in rs398652 (*PELI2*) were significantly associated with a higher rate of HTN incidence (OR, 1.179; 95% CIs, 1.040, 1.336).

###### Available reported SNPs and their association with telomere length related SNP and disease prevalence
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  Nearest gene     Reported SNP   Reference                    Availability   OA   MA   MAF    Hypertension           Coronary heart disease                          
  ---------------- -------------- ---------------------------- -------------- ---- ---- ------ ---------------------- ------------------------ ---------------------- -------
  ACYP2            rs11125529     Codd et al. \[[@B18]\]       Genotyped      C    A    0.15   0.948 (0.837, 1.074)   0.403                    0.938 (0.566, 1.554)   0.804
  SDHDP3-*TERC*    rs12696304     Prescott et al. \[[@B19]\]   Genotyped      G    C    0.29   1.091 (0.987, 1.206)   0.088                    1.431 (0.984, 2.080)   0.061
  *LRRC34*         rs10936601     Pooley et al. \[[@B20]\]     Genotyped      T    C    0.29   1.091 (0.988, 1.204)   0.085                    1.409 (0.971, 2.045)   0.071
  C5orf42          rs2098713      Saxena et al. \[[@B21]\]     Imputed        C    T    0.45   1.055 (0.964, 1.155)   0.244                    1.200 (0.840, 1.715)   0.317
  FAM162B          rs654128       Gu et al. \[[@B13]\]         Genotyped      C    A    0.04   1.064 (0.835, 1.356)   0.613                    1.331 (0.572, 3.094)   0.507
  *PELI2*          rs398652       Gu et al. \[[@B13]\]         Genotyped      A    G    0.39   1.059 (0.965, 1.161)   0.225                    1.196 (0.839, 1.703)   0.322
  KRT80            rs17635722     Liu et al. \[[@B22]\]        Genotyped      C    T    0.14   1.001 (0.877, 1.143)   0.985                    0.815 (0.465, 1.429)   0.476
  SYT16            rs4902100      Lee et al. \[[@B23]\]        Imputed        A    G    0.11   0.955 (0.824, 1.106)   0.538                    1.205 (0.700, 2.075)   0.502
  DCAF4            rs2535913      Mangino et al. \[[@B24]\]    Genotyped      G    A    0.18   0.957 (0.850, 1.078)   0.468                    1.118 (0.714, 1.750)   0.626
  CELF4-MIR4318    rs2162440      Mangino et al. \[[@B24]\]    Imputed        G    A    0.27   1.057 (0.954, 1.172)   0.289                    1.037 (0.63, 1.553)    0.859
  VN1R859-ZNF676   rs1975174      Levy et al. \[[@B25]\]       Imputed        T    G    0.32   1.000 (0.907, 1.103)   0.999                    0.932 (0.553, 1.252)   0.379
  *TERT*-CLPTM1L   rs401681       Stacey et al. \[[@B26]\]     Genotyped      C    T    0.36   1.072 (0.975, 1.178)   0.149                    0.994 (0.685, 1.444)   0.977

SNP, single nucleotide polymorphism; OA, other allele; MA, minor allele; MAF, minor allele frequencies; OR, odds ratio; CI, confidence interval.

^\*^Effect size is described with ORs are described with 95% CI and p value at a 0.05 significance level for each SNPs. ^†^Differences were tested using logistic regression model for disease prevalence after adjusting for sex, age, area, body mass index, education level, physical activity, smoking, and drinking.

![Association between disease prevalence and telomere related genotypes according to alcohol status. The forest plot was based on estimates from logistic regressions after adjustment for sex, age, area, body mass index, education level, physical activity, and smoking. In case of analysis within the non-alcohol users, previous alcohol use was additionally included in the regression model. ^\*^Indicated statistical significance at level of p \< 0.05.](cnr-5-249-g001){#F1}

Association between interesting SNPs and cardiovascular risk factors
--------------------------------------------------------------------

SNPs significantly associated with disease outcomes (rs1296304, rs10936601, and 398652) were selected, and their associations with cardiovascular risk factors were further evaluated ([Table 3](#T3){ref-type="table"}). Of 3 SNPs related to disease outcomes, rs1296304 was significantly associated with increased levels of DBP (β estimate, 0.470; 95% CIs, 0.013, 0.926). A minor allele in rs398652 was significantly associated with higher levels of BMI and γ-GTP (OR, 0.128; 95% CIs, 0.010, 0.246; OR, 0.013; 95% CIs, 0.001, 0.024). No association was observed between rs1093601 and tested risk factors.

###### Difference of biochemical markers among the subjects according to telomere related genotype
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  Cardiovascular risk factor               rs12696304               rs10936601   rs398652                                                 
  ---------------------------------------- ------------------------ ------------ ------------------------ ------- ----------------------- -------
  SBP, mmHg                                0.500 (−0.187, 1.186)    0.154        0.449 (−0.230, 1.129)    0.195   0.426 (−0.204, 1.057)   0.185
  DBP, mmHg                                0.470 (0.013, 0.926)     0.044        0.424 (−0.028, 0.876)    0.066   0.302 (−0.118, 0.721)   0.159
  BMI, kg/m^2^                             0.046 (−0.082, 0.175)    0.481        0.045 (−0.082, 0.172)    0.483   0.128 (0.010, 0.246)    0.034
  WC, cm                                   0.102 (−0.242, 0.445)    0.561        0.074 (−0.266, 0.414)    0.669   0.186 (−0.129, 0.501)   0.247
  Log-transformed FBG, log (mg/dL)^†^      0.002 (−0.002, 0.005)    0.343        0.001 (−0.002, 0.004)    0.511   0.001 (−0.002, 0.004)   0.547
  TC, mg/dL                                0.561 (−0.911, 2.033)    0.455        0.423 (−1.034, 1.880)    0.569   1.088 (−0.264, 2.439)   0.115
  Log-transformed HDLC, log (mg/dL)^†^     0.003 (−0.000, 0.007)    0.080        0.003 (−0.001, 0.007)    0.125   0.001 (−0.003, 0.004)   0.765
  LDLC, mg/dL                              0.385 (−0.952, 1.722)    0.572        0.293 (−1.031, 1.616)    0.665   0.774 (−0.457, 2.005)   0.218
  Log transformed TG, log (mg/dL)^†^       −0.004 (−0.013, 0.005)   0.406        −0.005 (−0.013, 0.004)   0.316   0.003 (−0.005, 0.011)   0.488
  Log-transformed γ-GTP, log (IU/L)^†^     −0.003 (−0.016, 0.009)   0.593        −0.003 (−0.016, 0.009)   0.578   0.013 (0.001, 0.024)    0.027
  Log-transformed hs-CRP, log (mg/dL)^†^   0.007 (−0.016, 0.029)    0.562        0.004 (−0.018, 0.026)    0.732   0.007 (−0.014, 0.027)   0.513

SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; WC, waist circumference; FBG, fasting blood glucose; TC, total cholesterol; HDLC, high density lipoprotein cholesterol; LDLC, low density lipoprotein cholesterol; TG, triglycerides; γ-GTP, gamma-glutamyl transpeptidase; hs-CRP, high sensitivity C reactive protein.

^\*^Estimates are presented as regression coefficient β, 95% confidence interval (CI). Corresponding p values were provided separately. These estimates were obtained from linear regression regressions with an ordinary least squares estimation method. All regression models were adjusted for sex, age, area, body mass index, education level, physical activity, smoking, and drinking. ^†^Values were used in statistical model after log-transformation to satisfy the assumption of normal distribution.

DISCUSSION
==========

In this study, we hypothesized that some previously known genetic variants related to TL are associated with the incidence of HTN/CHD in the Korean population. The results show that no significant association between the selected TL-related SNPs and disease outcome was observed in this population; however, variations in *TERC* (rs12696304) and *LRRC34* (rs10936601) tended to increase the ORs for HTN and CHD.

Several epidemiological studies have shown that age-dependent shortening of TL is associated with chronic diseases such as essential HTN, T2DM, CVD, and dementia \[[@B5][@B6][@B7][@B8][@B27]\]. It was reported that patients with CAD had a significantly shorter mean TL in their aortic cells, compared with subjects without heart disease \[[@B5]\]. Shorter TLs were also detected in patients with HTN, atherosclerosis, MI, chronic heart failure, stroke, even T2DM, than in control subjects \[[@B5][@B6][@B7]\]. In addition, prospective studies have reported a significantly shorter TL to be associated with increased risks of CAD, MI, and strokes \[[@B8]\]. These results raise the question as to whether genetic variations that affect TL should also be associated with disease risk.

So far, genetic variants at several loci have been found to be significantly associated with TL, through GWAS and meta-analyses \[[@B1][@B28][@B29][@B30][@B31]\]. Of these, the specific sequence variations within *TERT* and *TERC* genes were reported to cause variations in TL, with altered TL being a cause of some chronic diseases, including cancer and cardiac disease. This can be explained through the biology of telomeres. In humans, TL continuously decreases with aging because of a decrease in telomerase activity \[[@B32]\]. Telomerase is a large RNA-protein complex comprised of *TERT* and *TERC*. The enzyme maintains TL during DNA replication by catalyzing short telomere repeats, after recognizing a single stranded G-rich primer \[[@B18]\]. The downregulation of telomerase activity with aging leads to progressive telomere shortening, cell death, cellular senescence, or abnormal cell proliferation \[[@B33]\]. In line with this, a GWAS found that a SNP located within *TERT* (rs2736100, rs7705526, rs2736108) was significantly associated with TL \[[@B28]\]. Moreover, variations in *TERT*(rs2736122, rs2853668) affected the risk of CVD associated with TL in middle-aged adults \[[@B29]\], which was also validated in the Han Chinese population \[[@B30]\]. Although very little is known about the specific *LRRC* proteins, the *LRRC* superfamily includes proteins with a diverse array of structures, and involvement via protein--protein interactions in a variety of functions, including DNA repair, chromosomal stability, and heart development \[[@B18]\]. In contrast to previous findings, in this study, we failed to detect significant associations between selected TLs related SNPs and disease outcome, on the population level. This discrepancy might exist because of the different ethnic backgrounds of the study subjects, different and small sample sizes, and the different methods used to define CVD (self-reporting). Thus, a carefully designed large-scale study of well-phenotyped population would be needed in order to further investigate this discrepancy. However, we found that the associations between TL variations with HTN/CHD were modified by alcohol behavior. The association between SNPs in *TERC* and *LRRC34* and the prevalence of CHD were evident only in non-alcohol users. In addition, the association between the presence of rs398652 at *PELI2* and HTN prevalence was observed only in alcohol users, suggesting the presence of a potential interaction between TL-related SNPs and alcohol intake. Since cardiovascular dysfunctions are highly complex disease states correlated with both genetic and environmental factors, heritable variation would not be the only factor influencing TL. Accumulating data have shown that telomere shortening could be attributable to several risk factors for psychological stress, smoking, obesity, alcohol, chronic inflammation, and exposure to particulate air pollution \[[@B7][@B34]\]. Specifically, Pavanello et al. \[[@B34]\] reported that alcohol abuse was associated with shortened telomeres. Since telomeres are highly sensitive targets for damage due to oxidative stress \[[@B7]\], it could be hypothesized that high levels of 8-hydroxy-2\'-deoxyguanosine (8-OH-dG), a marker for DNA damage, may be formed by the process of alcohol metabolism. Because TL is also affected by other aging-related risk factors for HTN/CAD, it is possible that the observed association between TL-related SNPs and disease outcomes was confounded by CVD risk factors such as blood pressure, obesity, and blood lipid profiles. Indeed, the presence of rs1296304 at *SDHDP3-TERC* was significantly associated with increased levels of DBP. In addition, a minor allele in rs398652, which exhibited an association with CAD in alcohol users, was significantly associated with higher levels of BMI and γ-GTP. Future studies to investigate whether the association between TL and aging-related disease is primarily or secondarily mediated via CVD risk factors are needed in order to confirm these observations.

In summary, we have demonstrated that both variations in several genes encoding proteins with known functions in telomere biology and other genes are not associated with the prevalence of HTN/CHD in the Korean population. However, potential interaction between related SNPs and alcohol behavior were observed, suggesting that chronic disease development is a complex process driven by many different factors. Confirmation of the presence of a causal association between TL and HTN/CHD, and further mechanistic investigations of this relationship are needed in order to verify our results.
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